Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2025 ,inter alia, to consider and approve Allotment ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals has informed BSE that its Board of Directors will meet on Saturday, August 16, 2025 at 2:00 PM. The key agenda is to consider and approve the allotment of equity shares arising from the conversion of previously issued convertible equity share warrants held by subscribers. This is a procedural regulatory intimation filed under SEBI LODR Regulation 29. The letter is signed by Whole Time Director Venkata Rao Sadhanala (DIN: 02906370). No fresh fundraising is being announced—this is about converting existing instruments into equity shares.
This is a routine procedural filing confirming the conversion of previously issued warrants into equity shares, which may lead to a marginal increase in the company's outstanding share count and potential mild dilution for existing shareholders. Likely neutral to mildly negative for short-term share price due to dilution, but signals that warrant holders see value in converting to equity.